Related Experiment Videos
EMLA for painful procedures in infants
Karen L Weise1, Milap C Nahata
1University of California, San Francisco, USA.
Summary
EMLA (eutectic mixture of local anesthetics) provides effective pain relief for infants during procedures. It is approved for use in pediatric patients and its efficacy and adverse effects are discussed.
Area of Science:
- Pediatric Anesthesiology
- Dermatology
- Pain Management
Background:
- Infants experience pain during common medical procedures.
- Effective and safe pain management is crucial in pediatric care.
- EMLA (eutectic mixture of local anesthetics) is a topical anesthetic cream.
Purpose of the Study:
- To identify the components of EMLA and its youngest approved pediatric age.
- To list procedures where EMLA is used for infant pain control.
- To compare EMLA's efficacy against other pain management agents.
- To discuss potential adverse effects of EMLA in infants.
Main Methods:
- Literature review of studies on EMLA use in pediatric populations.
- Analysis of clinical trial data regarding EMLA efficacy and safety.
- Comparison of EMLA with placebo and alternative analgesic methods.
Main Results:
- EMLA contains lidocaine and prilocaine, approved for pediatric use from birth.
- Effective in reducing procedural pain for various infant interventions.
- Demonstrates comparable or superior efficacy to other topical agents.
Conclusions:
- EMLA is a safe and effective option for procedural pain management in infants.
- Understanding its application and potential adverse effects is vital for clinicians.
- Supports the use of EMLA as a first-line analgesic in pediatric settings.